Search Results - "Flynn, Noah"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs) from a retrospective electronic health record (EHR) cohort by Datta, Arghya, Flynn, Noah R., Barnette, Dustyn A., Woeltje, Keith F., Miller, Grover P., Swamidass, S. Joshua

    Published in PLoS computational biology (01-07-2021)
    “…Drug-drug interactions account for up to 30% of adverse drug reactions. Increasing prevalence of electronic health records (EHRs) offers a unique opportunity…”
    Get full text
    Journal Article
  2. 2

    Message Passing Neural Networks Improve Prediction of Metabolite Authenticity by Flynn, Noah R., Swamidass, S. Joshua

    “…Cytochrome P450 enzymes aid in the elimination of a preponderance of small molecule drugs, but can generate reactive metabolites that may adversely react with…”
    Get full text
    Journal Article
  3. 3

    XenoNet: Inference and Likelihood of Intermediate Metabolite Formation by Flynn, Noah R, Dang, Na Le, Ward, Michael D, Swamidass, S. Joshua

    “…Drug metabolism is a common cause of adverse drug reactions. Drug molecules can be metabolized into reactive metabolites, which can conjugate to biomolecules,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites by Hughes, Tyler B, Dang, Na Le, Kumar, Ayush, Flynn, Noah R, Swamidass, S. Joshua

    “…Adverse drug metabolism often severely impacts patient morbidity and mortality. Unfortunately, drug metabolism experimental assays are costly, inefficient, and…”
    Get full text
    Journal Article
  6. 6

    Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics by Schleiff, Mary Alexandra, Flynn, Noah R, Payakachat, Sasin, Schleiff, Benjamin Mark, Pinson, Anna O, Province, Dennis W, Swamidass, S Joshua, Boysen, Gunnar, Miller, Grover P

    Published in Drug metabolism and disposition (01-02-2021)
    “…Meclofenamate is a nonsteroidal anti-inflammatory drug used in the treatment of mild-to-moderate pain yet poses a rare risk of hepatotoxicity through an…”
    Get full text
    Journal Article
  7. 7

    CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches by Davis, Mary A, Barnette, Dustyn A, Flynn, Noah R, Pidugu, Anirudh S, Swamidass, S. Joshua, Boysen, Gunnar, Miller, Grover P

    Published in Chemical research in toxicology (17-06-2019)
    “…Lamisil (terbinafine) is an effective, widely prescribed antifungal drug that causes rare idiosyncratic hepatotoxicity. The proposed toxic mechanism involves a…”
    Get full text
    Journal Article
  8. 8

    Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin by Pouncey, Dakota L, Barnette, Dustyn A, Sinnott, Riley W, Phillips, Sarah J, Flynn, Noah R, Hendrickson, Howard P, Swamidass, S Joshua, Miller, Grover P

    Published in Frontiers in pharmacology (13-01-2022)
    “…Coumadin (R/S-warfarin) anticoagulant therapy is highly efficacious in preventing the formation of blood clots; however, significant inter-individual…”
    Get full text
    Journal Article
  9. 9

    Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors by Flynn, Noah R., Ward, Michael D., Schleiff, Mary A., Laurin, Corentine M. C., Farmer, Rohit, Conway, Stuart J., Boysen, Gunnar, Swamidass, S. Joshua, Miller, Grover P.

    Published in Metabolites (15-06-2021)
    “…The 3,5-dimethylisoxazole motif has become a useful and popular acetyl-lysine mimic employed in isoxazole-containing bromodomain and extra-terminal (BET)…”
    Get full text
    Journal Article
  10. 10

    Cal-Net: Jointly Learning Classification and Calibration On Imbalanced Binary Classification Tasks by Datta, Arghya, Flynn, Noah R., Swamidass, S. Joshua

    “…Datasets in critical domains are often class imbalanced, with a minority class far rarer than the majority class, and classification models face challenges to…”
    Get full text
    Conference Proceeding
  11. 11

    Novel Bioactivation of Isoxazole‐containing Bromodomain and Extra Terminal Domain (BET) Inhibitors by Miller, Grover, Schleiff, Mary, Flynn, Noah, Ward, Michael, Laurin, Coretine, Conway, Stuart, Swamidass, S.

    Published in The FASEB journal (01-05-2021)
    “…Bromodomain and extra‐terminal (BET) inhibitors comprise a growing class of anti‐cancer agents. New generations of BET inhibitors seek to capitalize on the…”
    Get full text
    Journal Article
  12. 12

    Modeling the Bioactivation and Subsequent Reactivity of Drugs by Hughes, Tyler B, Flynn, Noah, Dang, Na Le, Swamidass, S. Joshua

    Published in Chemical research in toxicology (15-02-2021)
    “…Electrophilically reactive drug metabolites are implicated in many adverse drug reactions. In this mechanismtermed bioactivationmetabolic enzymes convert…”
    Get full text
    Journal Article
  13. 13

    Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam by Barnette, Dustyn A., Schleiff, Mary A., Datta, Arghya, Flynn, Noah, Swamidass, S. Joshua, Miller, Grover P.

    Published in Toxicology letters (01-03-2021)
    “…[Display omitted] •Quantitative kinetics revealed enzyme roles in meloxicam/sudoxicam metabolism.•Thiazole methyl substituent alters enzyme specificity for…”
    Get full text
    Journal Article
  14. 14

    Computational Approaches for Screening Drugs for Bioactivation, Reactive Metabolite Formation, and Toxicity by Flynn, Noah

    Published 01-01-2021
    “…Cytochrome P450 enzymes aid in the elimination of a preponderance of small molecule drugs, but can generate reactive metabolites that may adversely conjugate…”
    Get full text
    Dissertation
  15. 15
  16. 16

    Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs cohort by Datta, Arghya, Flynn, Noah R, Barnette, Dustyn A, Woeltje, Keith F, Miller, Grover P, Swamidass, S. Joshua

    Published in PLoS computational biology (06-07-2021)
    “…Drug-drug interactions account for up to 30% of adverse drug reactions. Increasing prevalence of electronic health records (EHRs) offers a unique opportunity…”
    Get full text
    Journal Article
  17. 17

    Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam by Barnette, Dustyn A., Schleiff, Mary A., Osborn, Laura R., Flynn, Noah, Matlock, Matthew, Swamidass, S. Joshua, Miller, Grover P.

    Published in Toxicology (Amsterdam) (01-07-2020)
    “…[Display omitted] •Electron density increased modeled epoxidations but depended on substituent types.•Novel kinetics showed impact of thiazole methyl on…”
    Get full text
    Journal Article
  18. 18

    Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation by Barnette, Dustyn A., Davis, Mary A., Flynn, Noah, Pidugu, Anirudh S., Swamidass, S. Joshua, Miller, Grover P.

    Published in Biochemical pharmacology (01-12-2019)
    “…[Display omitted] Terbinafine N-dealkylation pathways result in formation of 6,6-dimethyl-2-hepten-4-ynal (TBF-A), a reactive allylic aldehyde, that may…”
    Get full text
    Journal Article
  19. 19